Kentaro Serizawa
Overview
Explore the profile of Kentaro Serizawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
38
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shinohara A, Shindo M, Nakano N, Sakaida E, Uchida N, Fukushima K, et al.
Eur J Haematol
. 2025 Jan;
PMID: 39834012
Fludarabine and myeloablative busulfan (FluBu4) in allogeneic hematopoietic stem cell transplantation (HSCT) for older people have not been adequately examined. This retrospective study analyzed data from a large-scale, nationwide database...
2.
Kawamura S, Nakagawa D, Nagayama T, Katayama Y, Doki N, Takeda W, et al.
Blood Adv
. 2025 Jan;
PMID: 39808797
In unrelated allogeneic hematopoietic cell transplantation (allo-HCT), older and/or HLA-mismatched donors are known risk factors for survival outcomes. In healthy individuals, cytomegalovirus (CMV) seropositivity is associated with impaired adaptive immune...
3.
Fukui-Morimoto A, Serizawa K, Fujimoto K, Hanamoto A, Iwata Y, Kakutani H, et al.
Int J Hematol
. 2024 Nov;
121(1):89-99.
PMID: 39531203
Despite the introduction of new drugs, multiple myeloma (MM) still remains incurable. We previously reported that CD34 MM cells, which are clonogenic and self-renewing, are therapy-resistant and persist as a...
4.
Kuriyama K, Fuji S, Ito A, Doki N, Katayama Y, Ohigashi H, et al.
Transplant Cell Ther
. 2024 Feb;
30(5):514.e1-514.e13.
PMID: 38373522
The purine analog fludarabine (Flu) plays a central role in reduced-intensity conditioning and myeloablative reduced-toxicity conditioning regimens because of limited nonhematologic toxicities. Few reports assess the impact of different dose...
5.
Yanada M, Yamasaki S, Kondo T, Kawata T, Harada K, Uchida N, et al.
Leukemia
. 2023 Dec;
38(3):513-520.
PMID: 38129514
Allogeneic hematopoietic cell transplantation (HCT) is the last option for long-term survival for patients with chemotherapy-refractory acute myeloid leukemia (AML). By using the Japanese nationwide registry data, we analyzed 6927...
6.
Hayashi H, Iwasaki M, Nakasone H, Tanoshima R, Shimabukuro M, Takeda W, et al.
Cytotherapy
. 2023 Dec;
26(2):178-184.
PMID: 38108686
Background Aims: This study aimed to comprehensively assess the impact of stem cell selection between bone marrow (BM) and peripheral blood (PB) in unrelated hematopoietic stem cell transplantation (HSCT) for...
7.
Kato K, Sugio T, Ikeda T, Yoshitsugu K, Miyazaki K, Suzumiya J, et al.
Bone Marrow Transplant
. 2023 Dec;
59(3):306-314.
PMID: 38102209
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a currative treatment modality for diffuse large B-cell lymphoma (DLBCL) because of the intrinsic graft-versus-lymphoma effect. However, limited information is available regarding which...
8.
Haeno T, Rai S, Miyake Y, Inoue M, Fujimoto K, Fujii A, et al.
J Clin Exp Hematop
. 2023 Apr;
63(2):99-107.
PMID: 37121716
We retrospectively evaluated long-term outcomes of high dose chemotherapy followed by autologous stem cell transplant (HDC/ASCT) in patients with diffuse large B-cell lymphoma (DLBCL). Between 2004 and 2020, 46 DLBCL...
9.
Fujiwara R, Taniguchi Y, Rai S, Iwata Y, Fujii A, Fujimoto K, et al.
Biochem Biophys Res Commun
. 2022 Aug;
626:156-166.
PMID: 35994825
We previously reported that the antipsychotic drug chlorpromazine (CPZ), which inhibits the formation of clathrin-coated vesicles (CCVs) essential for endocytosis and intracellular transport of receptor tyrosine kinase (RTK), inhibits the...
10.
Serizawa K, Tanaka H, Ueda T, Fukui A, Kakutani H, Taniguchi T, et al.
Int J Hematol
. 2022 Feb;
115(3):336-349.
PMID: 35133572
Side population (SP) is known to include therapy-resistant cells in various cancers. Here, we analyzed SP using multiple myeloma (MM) samples. The SP accounted for 2.96% in MM cells from...